Clinical significance of c-Met expression in patients with advanced gastroesophageal adenocarcinoma. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...
Outcome of TP53-mutated CCUS and the risk of progression to myeloid neoplasms. Jaktinib in patients (pts) with myelofibrosis (MF) who were intolerant to ruxolitinib (RUX): An open-label, single-arm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results